FDA product code CZY: Complement C1s, Antigen, Antiserum, Control

CZY is the FDA product code for complement c1s, antigen, antiserum, control. It is a Class II device, regulated under 21 CFR 866.5240 and reviewed by the Immunology panel. FDA has cleared 1 510(k) submission under CZY. The average 510(k) review took 30 days (median 30).

Classification

FieldValue
Device nameComplement C1s, Antigen, Antiserum, Control
Device classClass II
Regulation21 CFR 866.5240
Review panelIM — Immunology
Medical specialtyImmunology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every CZY clearance

Top CZY applicants

ApplicantClearancesLatest
Cytotech, Inc.11987-11-25

Most recent CZY clearances

510(k)ApplicantDeviceDecision dateReview days
K874379Cytotech, Inc.CIC-RAJI CELL REPLACEMENT ENZYME IMMUNOASSAY1987-11-2530

Recalls for CZY devices

openFDA lists no recalls for product code CZY.

Frequently asked questions

What is FDA product code CZY?

CZY is the FDA product code for complement c1s, antigen, antiserum, control. It is a Class II device, regulated under 21 CFR 866.5240 and reviewed by the Immunology panel.

What device class is CZY?

Class II, regulation 21 CFR 866.5240. Typical premarket route: 510(k).

How long does a 510(k) take for product code CZY?

Across 1 cleared submissions the average was 30 days from receipt to decision (median 30).

Which companies have the most CZY clearances?

Cytotech, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times